NTV Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$594K Buy
5,715
+14
+0.2% +$1.49K 0.07% 194
2025
Q4
$588K Buy
5,701
+599
+12% +$58.3K 0.06% 189
2025
Q3
$461K Sell
5,102
-2,855
-36% -$250K 0.05% 211
2025
Q2
$700K Sell
7,957
-1,215
-13% -$105K 0.08% 165
2025
Q1
$836K Buy
9,172
+1,463
+19% +$132K 0.11% 134
2024
Q4
$665K Buy
7,709
+271
+4% +$24.5K 0.09% 153
2024
Q3
$707K Buy
7,438
+341
+5% +$32.4K 0.09% 149
2024
Q2
$649K Buy
7,097
+2,102
+42% +$188K 0.09% 150
2024
Q1
$453K Buy
+4,995
New +$437K 0.07% 174
2023
Q1
Sell
-2,600
Closed -$202K 254
2022
Q4
$202K Buy
+2,600
New +$192K 0.04% 240
2016
Q4
Sell
-4,850
Closed -$278K 158
2016
Q3
$278K Sell
4,850
-800
-14% -$48K 0.1% 145
2016
Q2
$331K Sell
5,650
-300
-5% -$17.5K 0.13% 132
2016
Q1
$342K Hold
5,950
0.13% 134
2015
Q4
$388K Hold
5,950
0.15% 128
2015
Q3
$374K Hold
5,950
0.12% 154
2015
Q2
$420K Buy
+5,950
New +$428K 0.12% 153

Other funds holding PPH